Hot Investor Mandate 1: Early Stage Fund Invests Broadly in Healthcare Companies, Focuses on Oncology

2 Nov

An early stage fund with a China-based parent investment firm built its own science park near Shanghai to help companies expand successfully into the China market. The firm invests in 3 to 5 deals a year at seed stage. The fund has particular success in fostering joint development initiatives between U.S. and China-based companies. The firm invests in companies based in the U.S., China, or Europe.

The fund invests in early-stage therapeutics, medical devices, diagnostics, and healthcare IT. The firm is particularly interested in early-stage therapeutic companies, and their second priority would be diagnostics. The firm has expertise in the oncology field, and the firm is open to looking at orphan diseases. In addition, the firm is also open to lab equipment and drug development enabling technology.

The fund supports companies who have an international business model with desires to expand into the US, China, and/or Europe.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s

%d bloggers like this: